AdaptHealth Sells Diabetes Unit to Sharpen Focus on Sleep, Respiratory Growth

2 weeks ago 10

MarketBeat

Tue, August 11, 2026 astatine 9:04 AM CDT 5 min read

Key Points

Interested successful AdaptHealth Corp.? Here are 5 stocks we similar better.
AdaptHealth is selling its astir $600 cardinal diabetes concern to Cardinal Health and exiting definite e-commerce and drop-ship operations to simplify the institution and absorption connected sleep, respiratory and location aesculapian equipment.
The institution reported 16% second-quarter gross growth, but its caller West Coast capitated declaration is facing higher-than-expected work costs owed to utilization and hospital-ordering issues. AdaptHealth is moving with its spouse to amended the contract's economics.
Management sees beardown maturation imaginable successful slumber attraction done higher referrals, location investigating and integer tools. Capital priorities see integrated growth, reducing leverage to 2.5 times and pursuing targeted slumber and respiratory acquisitions.

3 Small-Cap Leaders Poised for Significant Growth

AdaptHealth (NASDAQ:AHCO) executives outlined the company's second-quarter performance, portfolio changes and plans to absorption superior connected sleep, respiratory and location aesculapian instrumentality businesses during a Canaccord league discussion.

Chief Executive Officer Suzanne Foster said the institution has spent the past 2 years integrating a concern assembled done much than 150 acquisitions, standardizing operations, improving capableness and reducing debt. The institution besides has been rationalizing its merchandise portfolio, a process Foster said mostly concluded successful the 2nd quarter.

→ SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat

Among the large actions, AdaptHealth announced the merchantability of its diabetes concern to Cardinal Health, spun retired its e-commerce concern and exited definite drop-ship proviso operations that are taxable to aboriginal competitory bidding. Foster said the moves are intended to simplify the institution and nonstop resources toward markets it considers much attractive.

Diabetes Sale and Cost Reductions

Foster said the diabetes cognition represented astir $600 cardinal of concern and had initially been stabilized aft facing declining maturation and operational issues. However, the institution yet concluded that the conception did not connection the expected cross-selling opportunities with its different operations.

→ Quantum Earnings Week: Winners and Losers Are Finally Emerging

She besides cited manufacture changes, including a displacement toward pharmacy benefits from aesculapian benefits and the expected instrumentality of competitory bidding. Foster said competing efficaciously would person required AdaptHealth to put further successful pharmacy capabilities and organisation infrastructure.

Read Entire Article